Supervised high-intensity interval training program tied to reductions in anxiety, fear of progression, hormonal symptoms, stress, fatigue
MONDAY, March 14, 2022 (HealthDay News) — High-intensity interval training may provide mental and physical health benefits for men on active surveillance for initial management of low-grade prostate cancer, according to a study published online Feb. 17 in The Journal of Urology.
Dong-Woo Kang, from the University of Alberta in Edmonton, Canada, and colleagues examined the effects of 12 weeks of high-intensity interval training versus usual care in 52 patients with prostate cancer on active surveillance. Patient-reported outcomes included prostate cancer-specific anxiety, fear of cancer progression, prostate cancer symptoms, quality of life, and psychological health outcomes (e.g., fatigue, stress, and self-esteem).
Adherence to high-intensity interval training was 96 percent. The researchers found that high-intensity interval training significantly improved total prostate cancer-specific anxiety (adjusted between-group mean difference, −2.7), as well as the fear of progression subscale, hormonal symptoms, perceived stress, fatigue, and self-esteem.
“Previous reports have suggested that exercise might help to manage anxiety in other cancer patient groups but our study is the first to show improvement in anxiety and fear of cancer progression experienced by men who opt for active surveillance,” a coauthor said in a statement. “The researchers call for larger studies to confirm their findings and to demonstrate the longer-term physical and mental health benefits of exercise for this growing group of patients.”
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Physical Activity Linked to Slower Cognitive, Motor Progression in Parkinson Disease
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Higher Intake of Saturated, Animal Fats May Increase Mortality in Prostate Cancer
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer
Focal Therapy Use Remains Uncommon in Nonmetastatic Prostate Cancer